Callisto Pharmaceuticals Report issue

For profit Phase 2
Founded: New York NY United States (1996)
Status: Acquired by Synergy Pharmaceuticals (2012) → now Bausch Health Companies (2019)

Organization Overview

First Clinical Trial
2004
NCT00086216
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Callisto Pharmaceuticals, Inc.